Fernwood Investment Management, LLC - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.

Quarter-by-quarter ownership
Fernwood Investment Management, LLC ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,584,033
-4.6%
379,702
-0.3%
2.37%
-3.2%
Q2 2023$6,898,773
-17.2%
380,727
+21.5%
2.45%
-23.5%
Q1 2023$8,332,397
+41.5%
313,248
+2.8%
3.20%
+31.3%
Q4 2022$5,887,396
+26.5%
304,573
+36.7%
2.44%
+24.1%
Q3 2022$4,653,000
+173.7%
222,757
+5.0%
1.96%
+167.7%
Q2 2022$1,700,000
-3.3%
212,210
+14.0%
0.73%
+18.8%
Q1 2022$1,758,000
-25.3%
186,110
+6.8%
0.62%
-19.9%
Q4 2021$2,353,000
-16.3%
174,260
+4.7%
0.77%
-20.2%
Q3 2021$2,810,000
-36.3%
166,447
+10.1%
0.96%
-33.9%
Q2 2021$4,410,000151,1111.46%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 5,839,160$98,565,00018.71%
CHI Advisors LLC 2,484,724$41,942,00012.24%
TRV GP IV, LLC 2,132,867$36,003,0008.17%
Bond & Devick Financial Network, Inc. 120,160$2,028,0001.68%
Fernwood Investment Management, LLC 166,447$2,810,0000.96%
Redmile Group, LLC 3,083,501$52,049,0000.91%
HARVARD MANAGEMENT CO INC 562,379$9,493,0000.56%
Grace Capital 48,058$808,0000.50%
Eventide Asset Management 2,183,238$36,853,0000.49%
Cormorant Asset Management, LP 482,413$8,143,0000.33%
View complete list of PLIANT THERAPEUTICS INC shareholders